JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265845

Human USP34 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

USP34 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon 3 and 8 bp deletion in exon 3.

View Alternative Names

Deubiquitinating enzyme 34, FLJ43910, KIAA0570, KIAA0729, MGC104459, UBP34_HUMAN, Ubiquitin carboxyl-terminal hydrolase 34, Ubiquitin specific protease 34, Ubiquitin thioesterase 34, Ubiquitin thiolesterase 34, Ubiquitin-specific-processing protease 34

2 Images
Sanger Sequencing - Human USP34 knockout HeLa cell line (AB265845)
  • Sanger seq

Unknown

Sanger Sequencing - Human USP34 knockout HeLa cell line (AB265845)

Allele-2 : 2 bp deletion in exon 3.

Sanger Sequencing - Human USP34 knockout HeLa cell line (AB265845)
  • Sanger seq

Unknown

Sanger Sequencing - Human USP34 knockout HeLa cell line (AB265845)

Allele-1 : 8 bp deletion in exon 3.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon 3 and 8 bp deletion in exon 3

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255928). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265845-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265845 Human USP34 knockout HeLa cell line", "number":"AB265845-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265845-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265845 Human USP34 knockout HeLa cell line", "number":"AB265845-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
USP34
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

USP34 also known as ubiquitin specific peptidase 34 is a deubiquitinating enzyme that plays an essential role in the removal of ubiquitin moieties from target proteins. It weighs approximately 440 kDa. It is present in various tissues with notable expression in the brain heart and skeletal muscles. As a hydrolase USP34 removes ubiquitin chains affecting the stability and activity of proteins involved in several cellular processes.
Biological function summary

Ubiquitin specific peptidase 34 regulates protein homeostasis by controlling the degradation of ubiquitinated proteins. Its activity influences pathways such as Wnt signaling where it interacts with components of this signal transduction pathway to modulate cellular responses. Although USP34 can act independently it may also partner with other proteins in cellular complexes to assist in its deubiquitinating roles and to maintain appropriate protein levels.

Pathways

USP34 significantly impacts Wnt signaling and the TGF-beta pathway. In the Wnt signaling pathway it targets the degradation of beta-catenin which is pivotal for transcriptional activation in various cells. In the TGF-beta pathway USP34's regulation is important for promoting correct cellular responses. It interacts with proteins like SMAD and AXIN helping to maintain the pathways' integrity and balance cellular proliferation.

Ubiquitin specific peptidase 34 has connections to cancer and neurodegenerative diseases. Dysregulation of its deubiquitinating activity can result in abnormal protein stabilization which is a contributing factor in tumor growth and progression. In neurodegenerative diseases impaired USP34 function affects neuronal proteins linking it to disorders such as Alzheimer's disease. Proteins like beta-amyloid and tau often involved in these conditions have indirect associations with the activity of USP34 highlighting its potential role in disease processes.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com